The financing was largely expected, but its final size is now clear. Epsilon was already a previously announced acquisition, and the company had indicated that new borrowing would help fund it. The new information is the scale: $200.0 million of additional term debt was raised, while revolving commitments increased by another $125.0 million.
| Credit facility | Before | After | Change |
|---|---|---|---|
| Term loans | $277.5M implied | $477.5M | +$200.0M |
| Revolving commitments | $225.0M implied | $350.0M | +$125.0M |
| Total commitments | $502.5M implied | $827.5M | +$325.0M |
| SOFR spread | 2.00%-2.75% | 1.75%-2.50% | Lower by 25 bps |
| Base-rate spread | 1.00%-1.75% | 0.75%-1.50% | Lower by 25 bps |
The cost of the financing improved, partially offsetting the added leverage. The new agreement lowers both the SOFR and base-rate spread ranges by 25 basis points and reduces undrawn revolver fees to 0.25%-0.40% from 0.30%-0.45%. 〔0〕 That is a genuine positive detail, but it does not eliminate the balance-sheet effect of funding a $295 million cash acquisition primarily with additional debt.
The net read is two-sided rather than a clean beat or miss. The $200 million term-loan increase provides the acquisition funding and general corporate liquidity, while the $125 million revolver expansion creates additional optional capacity rather than necessarily representing drawn debt. 〔1〕 Lower pricing is better than the prior facility, but the filing confirms a materially larger financing footprint. The next meaningful test is whether Epsilon's contribution supports the company's updated 2026 outlook.
Read the original 8-K on SEC EDGAR ↗